Evaluation of prognostic factors in AML. Preface.

Rowe, Jacob M

Evaluation of prognostic factors in AML. Preface. [electronic resource] - Best practice & research. Clinical haematology Dec 2011 - 485-8 p. digital

Publication Type: Congress; Editorial

1532-1924

10.1016/j.beha.2011.09.003 doi


Aged
Aminoglycosides--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents--administration & dosage
CCAAT-Enhancer-Binding Proteins--genetics
Cytarabine--administration & dosage
DNA (Cytosine-5-)-Methyltransferases--genetics
DNA Methyltransferase 3A
Europe--epidemiology
Gemtuzumab
Humans
Leukemia, Myeloid, Acute--diagnosis
Middle Aged
Mutation
Prognosis
Survival Analysis
United States--epidemiology